The Pharma Exec behind the First Approved Gene Therapy Is Hunting for His Next Big Break

Novartis’s retiring CEO hopes such treatments will soon be deployed against lymphoma, other cancers

-- Read more on ScientificAmerican.com


from Scientific American News http://ift.tt/2DCXXP5
via IFTTT
Previous
Next Post »

StatCounter